N-able (NABL): Assessing Valuation After Cybersecurity Platform Halts Ransomware Attack for CPA Firm

N-able (NABL) recently made headlines after CRS Technology Consultants used its cybersecurity platform to neutralize a ransomware attack on a CPA firm. As a result, no ransom was paid and business operations continued without disruption.

See our latest analysis for N-able.

While N-able’s swift role in halting a large-scale ransomware attack showcased the practical impact of its cyber resilience tools, the market has yet to reward the company’s progress. N-able’s share price is down 17.3% year-to-date, and its total shareholder return has fallen 38.7% over the past year. Momentum for the stock remains subdued despite the clear demonstration of its platform’s value, leaving open questions about how quickly this operational strength might translate into sustained investor confidence.

If recent security wins sparked your curiosity, it could be a smart move to broaden your search and see what’s emerging among See the full list for free.

After such an impressive operational win, but with shares still trading at a notable discount to analyst targets, is N-able now an undervalued cybersecurity play, or are investors simply anticipating the road ahead?

Advertisement

Most Popular Narrative: 16.7% Undervalued

With N-able’s last close at $7.65 and the most popular narrative putting fair value at $9.19, current pricing suggests a substantial gap between the market’s view and the analyst consensus. This sets the stage for a closer look at the assumptions powering this valuation.

Accelerating adoption of cloud technologies and the shift toward unified, integrated platforms has increased demand for N-able's end-to-end cyber resilience platform. This has positioned the company to capture a larger share of the expanding IT management and cybersecurity market, which could drive sustained ARR and top-line revenue growth.

Read the complete narrative.

Want to know why the fair value climbs so high? The story behind these bold estimates centers on industry transformation and future profit margins rarely seen at this size. Uncover which numbers are moving the needle and get ahead of the market’s next move.

Result: Fair Value of $9.19 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, rapid industry consolidation or the rise of automation could pressure N-able’s margins and challenge its ability to deliver on these growth forecasts.

Find out about the key risks to this N-able narrative.

Build Your Own N-able Narrative

If you have a different perspective or want to see how your own research stacks up, it’s easy to craft your narrative and see where it leads. Do it your way

A great starting point for your N-able research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.

Looking for More Investment Ideas?

Make your next move count by tapping ready-made picks across exciting sectors. Don't let these chances slip by while great opportunities are getting snapped up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if N-able might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:NABL

N-able

Provides unified endpoint management, security operations, and data protection solutions worldwide.

Undervalued with adequate balance sheet.

Similar Companies

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0